Firebrick Pharma Limited (ASX:FRE)
0.0680
-0.0020 (-2.86%)
Apr 29, 2025, 3:37 PM AEST
Firebrick Pharma Revenue
Firebrick Pharma had revenue of 197.07K AUD in the half year ending December 31, 2024, with 773.92% growth. This brings the company's revenue in the last twelve months to 1.13M, down -37.71% year-over-year. In the fiscal year ending June 30, 2024, Firebrick Pharma had annual revenue of 2.75M with 12,096.48% growth.
Revenue (ttm)
1.13M
Revenue Growth
-37.71%
P/S Ratio
13.50
Revenue / Employee
n/a
Employees
n/a
Market Cap
15.27M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 2.75M | 2.73M | 12,096.48% |
Jun 30, 2023 | 22.55K | -1.06M | -97.92% |
Jun 30, 2022 | 1.08M | 661.35K | 156.72% |
Jun 30, 2021 | 422.00K | -86.98K | -17.09% |
Jun 30, 2020 | 508.98K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Telix Pharmaceuticals | 783.21M |
Ramsay Health Care | 17.12B |
Ansell | 3.00B |
Mesoblast | 9.16M |